Summary Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
All Keywords
【저자키워드】 COVID-19, Epidemiology, psychiatry, Psychopharmacology, prescribing, 【초록키워드】 knowledge, COVID-19 pandemic, medication, Safe, clinical experience, pharmacological, FIVE, lack, arising, 【제목키워드】 COVID-19 pandemic, medication,
【저자키워드】 COVID-19, Epidemiology, psychiatry, Psychopharmacology, prescribing, 【초록키워드】 knowledge, COVID-19 pandemic, medication, Safe, clinical experience, pharmacological, FIVE, lack, arising, 【제목키워드】 COVID-19 pandemic, medication,